Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Grant or award EVP, Chief Business Officer acquired 3,472 shares (grant or award)
  2. 4 Grant or award EVP/Chief Medical Officer acquired 4,243 shares (grant or award)
  3. 4 Grant or award EVP, Chief Scientific Officer acquired 9,084 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 4,471 shares (grant or award)
  5. 4 Grant or award CEO acquired 36,477 shares (grant or award)
  6. 4 Open-market sale EVP/Chief Medical Officer sold 1,568 shares at $38.33 ($60,101)
  7. 4 Open-market sale EVP, Chief Business Officer sold 287 shares at $40.61 ($11,655)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 4 Open-market sale CEO sold 13,805 shares at $38.03 ($525,033)
  14. CT ORDER Other Confidential Order
  15. 4 Grant or award CEO acquired 36,478 shares (grant or award)
  16. 8-K Event Regulation FD disclosure · Other events
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Executive or director change
  20. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $60.00 ($150,000)

Page 16 of 37 · 731 filings